Rapidly Disintegrating Dosage Form
The invention provides a rapidly disintegrating dosage form comprising a partially-coated tablet having at least one elongated groove along its surface, such that a portion of the at least one elongated groove extends beneath the coating.
1 . A dosage form comprising:
a core having at least one elongated groove;
a first coating end over a first end of the core; and
a second coating end over a second end of the core,
wherein the first coating end and the second coating end cover less than all of the core such that a first portion of the at least one elongated groove is exposed and a second portion of the at least one elongated groove extends beneath at least one of the first coating end and the second coating end.
2 . The dosage form of claim 1 , wherein the at least one elongated groove is oriented substantially parallel to a longitudinal axis of the core.
3 . The dosage form of claim 1 , wherein the core is one of: a compressed tablet and a molded tablet.
4 . The dosage form of claim 1 , wherein at least one of the first coating end and the second coating end contains a gelatin.
5 . The dosage form of claim 1 , wherein the core includes at least two elongated grooves oriented substantially parallel to each other.
6 . The dosage form of claim 1 , wherein the at least one elongated groove provides a surface area of the core greater than a surface area of a core of the same size not having a groove.
7 . The dosage form of claim 6 , wherein the core has at least one of a rate of dissolution and a rate of disintegration greater than a core of the same size not having a groove.
8 . The dosage form of claim 1 , wherein a length of the first portion of the at least one elongated groove comprises between about 1% and about 75% of a length of the second portion of the at least one elongated groove.
9 . A method for improving at least one of a rate of disintegration and an extent of disintegration in a tablet dosage form, the method comprising:
forming in a surface of a tablet at least one groove,
wherein the at least one groove increases a surface area of the tablet.
10 . The method of claim 9 , wherein the at least one groove is elongated and is oriented substantially parallel to a longitudinal axis of the tablet.
11 . The method of claim 9 , wherein the tablet is one of: a compressed tablet and a molded tablet.
12 . The method of claim 9 , wherein forming includes forming at least two grooves in the surface of the tablet oriented substantially parallel to each other.
13 . A method for producing a dosage form, the method comprising:
applying to a first end of a core having at least one elongated groove a first coating end; and
applying to a second end of the core a second coating end,
wherein the first and second coating ends, together, cover less than all of the core, and wherein at least one of the first coating end and the second coating end covers a first portion of the at least one elongated groove and neither the first coating end nor the second coating end covers a second portion of the at least one elongated groove.
14 . The method of claim 13 , wherein the at least one groove is elongated and is oriented substantially parallel to a longitudinal axis of the core.
15 . The method of claim 13 , wherein the core is one of: a compressed tablet and a molded tablet.
16 . The method of claim 13 , wherein at least one of the first coating end and the second coating end contains a gelatin.
17 . The method of claim 13 , wherein the core includes at least two elongated grooves oriented substantially parallel to each other.
18 . The method of claim 13 , wherein the at least one elongated groove provides a surface area of the core greater than a surface area of a core of the same size not having a groove.
19 . The method of claim 18 , wherein the core has at least one of a rate of dissolution and a rate of disintegration greater than a core of the same size not having at least one elongated groove.
20 . The method of claim 13 , further comprising:
forming the at least one elongated groove in a surface of the core.